Cargando…
An N-Cadherin 2 expressing epithelial cell subpopulation predicts response to surgery, chemotherapy and immunotherapy in bladder cancer
Neoadjuvant chemotherapy (NAC) prior to surgery and immune checkpoint therapy (ICT) have revolutionized bladder cancer management. However, stratification of patients that would benefit most from these modalities remains a major clinical challenge. Here, we combine single nuclei RNA sequencing with...
Autores principales: | Gouin, Kenneth H., Ing, Nathan, Plummer, Jasmine T., Rosser, Charles J., Ben Cheikh, Bassem, Oh, Catherine, Chen, Stephanie S., Chan, Keith Syson, Furuya, Hideki, Tourtellotte, Warren G., Knott, Simon R. V., Theodorescu, Dan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8361097/ https://www.ncbi.nlm.nih.gov/pubmed/34385456 http://dx.doi.org/10.1038/s41467-021-25103-7 |
Ejemplares similares
-
Cell death-induced immunogenicity enhances chemoimmunotherapeutic response by converting immune-excluded into T-cell inflamed bladder tumors
por: Nikolos, Fotis, et al.
Publicado: (2022) -
Integrative multi-omics analysis of muscle-invasive bladder cancer identifies prognostic biomarkers for frontline chemotherapy and immunotherapy
por: Mo, Qianxing, et al.
Publicado: (2020) -
Role of Bladder Cancer Metabolic Reprogramming in the Effectiveness of Immunotherapy
por: Scholtes, Mathijs P., et al.
Publicado: (2021) -
Single-cell profiling of murine bladder cancer identifies sex-specific transcriptional signatures with prognostic relevance
por: Abdel-Hafiz, Hany A., et al.
Publicado: (2023) -
Identifying novel biomarkers associated with bladder cancer treatment outcomes
por: Castaneda, Peris R., et al.
Publicado: (2023)